| Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non … L Jørgensen, AS Paludan-Müller, DRT Laursen, J Savović, I Boutron, ... Systematic reviews 5, 1-13, 2016 | 297 | 2016 |
| Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study H Moustgaard, GL Clayton, HE Jones, I Boutron, L Jørgensen, ... bmj 368, 2020 | 225 | 2020 |
| Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysis K Munkholm, AS Paludan-Müller, K Boesen BMJ open 9 (6), e024886, 2019 | 162 | 2019 |
| Randomized clinical trials with run-in periods: frequency, characteristics and reporting DRT Laursen, AS Paludan-Müller, A Hróbjartsson Clinical Epidemiology, 169-184, 2019 | 57 | 2019 |
| Hand cleaning with ash for reducing the spread of viral and bacterial infections: a rapid review Cochrane Infectious Diseases Group, AS Paludan-Müller, K Boesen, ... Cochrane Database of Systematic Reviews 2020 (7), 1996 | 33 | 1996 |
| Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non … L Jørgensen, AS Paludan-Müller, DR Laursen, J Savović, I Boutron, ... Epub 2016/05/11, 0 | 29 | |
| Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults K Boesen, AS Paludan-Müller, PC Gøtzsche, KJ Jørgensen Cochrane Database of Systematic Reviews, 2022 | 26 | 2022 |
| Mechanisms and direction of allocation bias in randomised clinical trials A Paludan-Müller, DR Teindl Laursen, A Hróbjartsson BMC medical research methodology 16, 1-10, 2016 | 24 | 2016 |
| Active placebo versus standard placebo control interventions in pharmacological randomised trials DRT Laursen, C Hansen, AS Paludan-Müller, A Hróbjartsson The Cochrane Database of Systematic Reviews 2020 (7), 2020 | 13 | 2020 |
| Reporting of harms in oncological clinical study reports submitted to the European Medicines Agency compared to trial registries and publications—a methodological review AS Paludan-Müller, P Créquit, I Boutron BMC medicine 19, 1-15, 2021 | 11 | 2021 |
| Extensive selective reporting of quality of life in clinical study reports and publications of placebo-controlled trials of antidepressants AS Paludan-Müller, T Sharma, K Rasmussen, PC Gøtzsche International Journal of Risk & Safety in Medicine 32 (2), 87-99, 2021 | 9 | 2021 |
| Do protocols for new randomised trials take previous similar trials into account? Cohort study of contemporary trial protocols AS Paludan-Müller, MC Ogden, M Marquardsen, J Vive, KJ Jørgensen, ... BMJ open 9 (11), e026661, 2019 | 8 | 2019 |
| Breast cancer screening and diagnosis KJ Jørgensen, AS Paludan-Müller Annals of Internal Medicine 172 (12), 838-839, 2020 | 5 | 2020 |
| Impact of active placebo controls on estimated drug effects in randomised trials: a systematic review of trials with both active placebo and standard placebo DRT Laursen, CH Nejstgaard, E Bjørkedal, AD Frost, MR Hansen, ... Cochrane Database of Systematic Reviews, 2023 | 4 | 2023 |
| Substantial delays in clinical data published by the European Medicines Agency–a cross sectional study AS Paludan-Müller, IR Maclean-Nyegaard, K Munkholm Journal of Clinical Epidemiology 146, 68-76, 2022 | 4 | 2022 |
| Electroconvulsive therapy for depression K Munkholm, KJ Jørgensen, AS Paludan-Müller Cochrane Database of Systematic Reviews 2021 (1), CD013843, 2021 | 4 | 2021 |
| Pharmacological treatments for generalised anxiety disorder K Munkholm, K Boesen, AS Paludan-Müller The Lancet 394 (10205), 1229, 2019 | 3 | 2019 |
| Combination antidepressant therapy vs monotherapy—further considerations K Munkholm, AS Paludan-Müller JAMA psychiatry 79 (8), 831-831, 2022 | 2 | 2022 |
| Electroconvulsive therapy for preventing relapse and recurrence in people with depression K Munkholm, KJ Jørgensen, AS Paludan-Müller The Cochrane Database of Systematic Reviews 2022 (1), 2022 | 2 | 2022 |
| Caution is advised when interpreting subgroup analyses K Munkholm, AS Paludan-Müller Neuropsychopharmacology 46 (9), 1551-1551, 2021 | 2 | 2021 |
